Concurrent participation in screening for cervical, breast, and bowel cancer in England.
Aged
Breast Neoplasms
/ diagnosis
Case-Control Studies
Colorectal Neoplasms
/ diagnosis
Early Detection of Cancer
/ statistics & numerical data
Employment
England
Female
General Practice
Humans
Middle Aged
Patient Acceptance of Health Care
/ statistics & numerical data
Preventive Medicine
State Medicine
Uterine Cervical Neoplasms
/ diagnosis
Breast cancer
bowel cancer
cervical cancer
participation
screening
Journal
Journal of medical screening
ISSN: 1475-5793
Titre abrégé: J Med Screen
Pays: England
ID NLM: 9433359
Informations de publication
Date de publication:
03 2020
03 2020
Historique:
pubmed:
17
9
2019
medline:
16
1
2021
entrez:
17
9
2019
Statut:
ppublish
Résumé
To determine how many women participate in all three recommended cancer screening programmes (breast, cervical, and bowel). During their early 60s, English women receive an invitation from all the three programmes. For 3060 women aged 60–65 included in an England-wide breast screening case–control study, we investigated the number of screening programmes they participated in during the last invitation round. Additionally, using the Fingertips database curated by Public Health England, we explored area-level correlations between participation in the three cancer screening programmes and various population characteristics for all 7014 English general practices with complete data. Of the 3060 women, 1086 (35%) participated in all three programmes, 1142 (37%) in two, 526 (17%) in one, and 306 (10%) in none. Participation in all three did not appear to be a random event (p < 0.001). General practices from areas with less deprivation, with more patients who are carers or have chronic illnesses themselves, and with more patients satisfied with the provided service were significantly more likely to attain high coverage rates in all programmes. Only a minority of English women is concurrently protected through all recommended cancer screening programmes. Future studies should consider why most women participate in some but not all recommended screening.
Identifiants
pubmed: 31525303
doi: 10.1177/0969141319871977
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-17Subventions
Organisme : Cancer Research UK
ID : C8162/A16892
Pays : United Kingdom